Avricore Health Inc experienced a notable price movement this week as it continues to navigate its growth strategy in the healthcare sector.
Avricore Health Inc (AVCR.V) has seen its stock price remain steady despite recent developments, but its performance has fluctuated over the past week. As investors look to understand the implications of the company’s recent activities, we take a closer look at the price action and the factors influencing it.
Investor takeaway: With a market cap of approximately $7.58 million and significant recent financing, Avricore Health Inc is focusing on expanding its HealthTab™ platform in the UK. Investors should consider the implications of this expansion strategy amidst current stock performance.
Advertisement
Avricore Health Inc
AVCR.V
AVCR.V
Avricore Health Inc
WealthAwesomeMarket cap
$7.58M
52W high
$0.10
52W low
$0.04
1W change
-14.29%
Beta
0.36
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
212.4%
Annualized
90-Day Vol
155.3%
Annualized
Trend (90d)
+36.5%
Annualized drift
90d Mean
C$0.07
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.03 – C$0.13 |
| 60 trading days | C$0.07 | C$0.02 – C$0.18 |
| 90 trading days | C$0.07 | C$0.02 – C$0.24 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Avricore Health Inc's stock closed at C$0.06, unchanged for the day.
The stock has fluctuated between C$0.04 and C$0.10 over the past year, indicating a relatively stable trading range despite recent volatility.
Bull case
The recent completion of a $1.254 million financing round positions Avricore Health to enhance its growth strategy, particularly in the UK market. The collaboration with Abbott for point-of-care testing products further strengthens its product offering and market presence.
Bear case
Despite the recent financing and collaborations, Avricore Health's stock has declined by 14.29% over the past week, reflecting potential investor caution amid broader market conditions or company-specific concerns. The company's high beta of 0.36 indicates lower volatility compared to the market, which may impact trading activity.
Recent Price Action
Advertisement
Avricore Health Inc's stock closed at C$0.06, reflecting no change for the day. However, the stock has seen a decline of 14.29% over the past week, which may raise concerns among investors. Year-to-date, the stock has appreciated by 9.09%, indicating some resilience amidst fluctuations.
Company Developments
Recent news surrounding Avricore Health includes the completion of a financing round that raised C$1.254 million intended for the company's expansion in the UK market. Additionally, the company announced a collaboration with Abbott to supply point-of-care testing products through its HealthTab™ platform. This partnership could enhance Avricore's market presence and product offerings.
Technical Picture
From a technical perspective, Avricore Health's stock is currently trading at its 50-day moving average of C$0.06, which is slightly below the average. The stock's 200-day moving average is also C$0.06, indicating a period of consolidation. The 52-week trading range of C$0.04 to C$0.10 shows that the stock has traded at 27% of its range over the past year. Notably, the current trading volume of 297,321 shares significantly exceeds the 20-day average volume of 57,941 shares, suggesting increased investor interest.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
